Medical News

RSS

Proton Therapy USA, CareCapital form Proton Therapy Global Management

Proton Therapy USA and CareCapital plc announced today the formation of Proton Therapy Global Management (PTGM). The Company will design, develop and manage a global network of proton therapy centers, providing access to this specialized and highly effective treatment to the world's growing population of cancer patients. Proton therapy is a precise form of radiation treatment that has been very successful in treating a wide range of localized tumors, while leaving healthy tissue mostly intact.

30 Jun 2010

SeqWright, RainDance Technologies partner to offer RainStorm microdroplet-based PCR technology

SeqWright Inc., a world-wide leader in custom genomic and molecular biology services, announced today the expansion of its service portfolio by partnering with RainDance Technologies to offer the company's innovative RainStorm™ microdroplet-based PCR technology. SeqWright recognizes the growing demand from life science researchers for more efficient and cost-effective processes that allow for automated workflows providing greater confidence in results to meet the needs of large-scale resequencing studies.

30 Jun 2010

Investment report on BioCryst Pharmaceuticals

MicroStockProfit.com announces an investment report featuring BioCryst Pharmaceuticals Inc.. The report includes financial, comparative and investment analyses, and recent company news that you need to know to make an educated investment decision.

30 Jun 2010

Fresenius Medical Care to acquire KNC and expand dialysis services business in Russian Federation

Fresenius Medical Care AG & Co. KGaA, the world's largest provider of dialysis products and services, is expanding its dialysis services business in the Russian Federation. The company announced today that it has signed an agreement to acquire KNC (KRAEVOY NEFROLOGICHESKIY CENTR), a private operator of dialysis clinics in Russia's Krasnodar region. The acquired operations will add approximately $25 million in annual revenue and are expected to be accretive to earnings in the first year after closing of the transaction.

30 Jun 2010

AMI study finds India's healthcare sector set to spend over $250M on IT in 2010

Seemingly untouched by the worldwide economic downturn, India's healthcare sector is set to spend over US$250 million on IT in 2010. Healthcare in India comprises more than 5% of the nation's GDP and displays a healthy growth rate over the next four to five years. This comes from a study by New York-based Access Markets International (AMI) Partners, Inc., a leading consulting firm specializing in IT and telecom sectors.

30 Jun 2010

Chelsea completes enrollment in Northera Phase III Study 301 for neurogenic orthostatic hypotension

Chelsea Therapeutics International, Ltd. has successfully reached its target enrollment of 150 patients in its Northera™ (Droxidopa) pivotal Phase III Study 301 for the treatment of symptomatic, neurogenic orthostatic hypotension (NOH). Results from the trial are expected in September 2010 and the full registration program is on track to initiate a new drug application (NDA) in the first half of 2011.

30 Jun 2010

BioSante reports positive results from Phase II study of Pill-Plus "triple hormone" oral contraceptive

BioSante Pharmaceuticals, Inc. announced today positive results in a Phase II study of the Pill-Plus "triple hormone" oral contraceptive (OC). Results showed an increase in the frequency of sexual activity (p< 0.05) and reduced frequency of rejection of initiation of sexual activity by partner (p< 0.05).

30 Jun 2010

Transition commences dosing in TT-301 Phase 1 clinical study for rheumatoid arthritis, ICH, TBI

Transition Therapeutics Inc. announced today that the first patient has been dosed with drug candidate TT-301 in a Phase 1 clinical study. TT-301 is a small molecule compound that has demonstrated efficacy in preclinical models of rheumatoid arthritis, intracerebral haemorrhage and traumatic brain injury.

30 Jun 2010

GE Capital to provide Swift Group £30 million of dealer stocking funds

GE Capital announced that it agreed to provide Swift Group Ltd, the UK's leading manufacturer of caravans, motorhomes and holiday homes, with a distribution finance facility that will provide the company with an estimated £30 million of dealer stocking funds in 2010.

30 Jun 2010

First Edition: June 30, 2010

Today's headlines highlight the results of a new tracking poll that indicate that the health reform law has gained popularity among Americans while implementation advances for overhaul initiatives such as high-risk pools and the early retiree reinsurance program.

30 Jun 2010

Epigentek develops new approach for identification of "sixth DNA base" 5-hmC

Research experts in the epigenetic field from Epigentek have developed a new, breakthrough approach for the identification of the "sixth DNA base," 5-hydroxymethylcytosine (5-hmC). This technology is based on a high throughput, strip-well format and is also incorporated into the first commercially available product, the MethylFlash(TM) Hydroxymethylated DNA Quantification Kit, for rapidly quantifying hydroxymethylated DNA.

30 Jun 2010

AdVnt launches 15 Minute Black Mold Detection Test

AdVnt Biotechnologies, the company known for producing BioWarfare Agent Detection Devices for HAZMAT First Response Teams around the globe to help them rapidly detect such biological agents as Anthrax, Ricin and Botulinum, has just released its newest product for In-Home and Professional use. Building on the expertise gained in the international arena of BioWarfare Agent Detection, AdVnt is now applying its R&D expertise to help defend against another type of bio threat that could be growing in the walls and under the floorboards in your own home.

30 Jun 2010

Blue Shield of California offers SilverSneakers Fitness Program to Medicare Supplement Plan subscribers

Blue Shield of California is now offering the Healthways SilverSneakers® Fitness Program to subscribers of Blue Shield Medicare Supplement Plans throughout California. SilverSneakers, the nation's leading social support and exercise program designed to keep seniors healthy, has been a popular benefit with California Medicare HMOs, but Blue Shield is one of the few health plans in the state to offer the benefit as part of its Medicare Supplement plans as well.

30 Jun 2010

Integra LifeSciences VP honored as Fellow of the American Academy of Nursing

Integra LifeSciences Holdings Corporation announced today that Linda Littlejohns RN MSN CCRN CNRN, Vice President, Clinical Development at Integra, has been selected as a Fellow of the American Academy of Nursing, one of the most prestigious nursing organizations in the country. The Academy's Fellows include many of the nation's top nursing executives, policymakers, scholars, researchers and practitioners.

30 Jun 2010

Advanced 3D/4D ultrasound to guide embryo transfer during IVF reduces risk of ectopic pregnancy

Using advanced 3D/4D ultrasound to guide embryo transfer during in vitro fertilization (IVF) significantly reduces a woman's risk of ectopic pregnancy and its associated complications, Robert Gergely, M.D., medical director, 3D Sonography Center of Beverly Hills, reported today.

30 Jun 2010

ERC awards VIB-K.U.Leuven scientists 3 million euros in research grants

VIB landed two research grants worth 1.5 million euros each. The prestigious grants are courtesy of the European Research Council (ERC) and are aimed at giving talented young scientists the opportunity to develop their own research team. The honor fell to Adrian Liston and Patrik Verstreken, both recently transferred to VIB-K.U.Leuven from abroad.

30 Jun 2010

Raptor partners with Uni Pharma to commercialize Convivia in Taiwan

Raptor Pharmaceutical Corp., announced that it has entered into an exclusive agreement with Uni Pharma Co., Ltd. to commercialize Convivia™, Raptor's proprietary oral formulation of 4-methylpyrazole, in Taiwan.

30 Jun 2010

Concord Medical board authorizes $20 million share repurchase program

Concord Medical Services Holdings Limited, operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that its board of directors approved a share repurchase program, effective immediately.

30 Jun 2010

Cerapedics' i-FACTOR Flex bone graft product line receives CE Mark

Cerapedics, Inc., a medical device company focused on developing and commercializing novel osteobiologic products, announced today that it received the CE Mark for its i-FACTOR™ Flex bone graft product line. i-FACTOR Flex is the company's second product in the i-FACTOR product platform based on its proprietary small peptide attachment factor technology.

30 Jun 2010

China Jo-Jo Drugstores fourth-quarter revenues up 39.6% to $16.3 million

China Jo-Jo Drugstores, Inc., which operates a retail pharmacy chain in the People's Republic of China, today reported full and fourth quarter financial results for the fiscal year ended March 31, 2010.

30 Jun 2010